Completed OBSERVATIONAL NCT04710329

High-Dose Vitamin C Treatment in Critically Ill COVID-19 Patients

High-Dose Vitamin C Treatment in Critically Ill COVID-19 Patients, A Retrospective Cohort Study

Sponsor: Sisli Hamidiye Etfal Training and Research Hospital

Conditions Covid19 Respiratory Distress Syndrome, Adult

Updated 5 times since 2021 Last updated: Feb 10, 2021 Started: Jan 16, 2021 Primary completion: Jan 25, 2021 Completion: Feb 10, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04710329, this observational or N/A phase trial focuses on Covid19 and Respiratory Distress Syndrome, Adult and remains completed. Sponsored by Sisli Hamidiye Etfal Training and Research Hospital, it has been updated 5 times since 2021, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Mar 2021 — Jul 2024 [monthly]

Completed

Status: Active Not Recruiting → Completed
Feb 2021 — Mar 2021 [monthly]

Active Not Recruiting

First recorded

Jan 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sisli Hamidiye Etfal Training and Research Hospital

Data source: Sisli Hamidiye Etfal Training and Research Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Şişli, Turkey (Türkiye)